References
Ashing-Giwa, K., Padilla, G., Tejero, J., Kraemer, J., Wright, K., Coscarelli, A., … Hills, D. (2004). Understanding the breast cancer experience of women: A qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psycho-Oncology, 13, 408-428. doi:10.1002/pon.750
Baum, M., Buzdar, A., Cuzick, J., Forbes, J., Houghton, J., Howell, A., … Arimidex, Tamoxifen Alone or in Combination Trialists' Group. (2003). Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial efficacy and safety update analyses. Cancer, 98, 1802-1810. doi:10.1002/cncr.11745
Breast International Group 1-98 Collaborative Group. (2005). A comparison of letrozole and tamoxifen in postmenopausal women with early stage breast cancer. New England Journal of Medicine, 353, 2747-2757.
Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., … Griggs, J. J. (2010). American Society of Clinical Oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. Journal of Clinical Oncology, 28, 3784-3796.
Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., … van de Velde, C. (2004). A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine, 350, 1081-1092. doi:10.1056/NEJMoa040331
Cuzick, J., Sestak, I., Cella, D., & Fallowfield, L. (2008). Treatment-emergent endocrine symptoms and the risk of breast cancer recur-rence: A retrospective analysis of the ATAC trial. Lancet Oncology, 9, 1143-1158. doi:10.1016/S1470-2045(08)702596
Fallowfield, L., Cella, D., Cuzick, J., Francis, S., Locker, G., & Howell, A. (2004). Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. Journal of Clinical Oncology, 22, 4261-4271.
Fellowes, D., Fallowfield, L. J., Saunders, C. M., & Houghton, J. (2001). Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for "well tolerated" treatments? Breast Cancer Research and Treatment, 66(1), 73-81. doi:10.1023/A:1010684903199
Fink, A. K., Gurwitz, J., Rakowski, W., Guadagnoli, E., & Silliman, R. A. (2004). Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. Journal of Clinical Oncology, 22, 3309-3315. doi:10.1200/JCO.2004.11.064
Fisher, B., Jeong, J. H., Bryant, J., Anderson, S., Dignam, J., Fisher, E. R., & Wolmark, N. (2004). Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: Long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Lancet, 364(9437), 858-868. doi:10.1016/S0140-6736(04)16981-X
Gennari, A., Sormani, M., Pronzato, P., Puntoni, M., Colozza, M., Pfeffer, U., & Bruzzi, P. (2008). HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: A pooled analysis of randomized trials. Journal of the National Cancer Institute, 100, 14-20.
Glass, A. G., Lacey, J.V, Jr., Carreon, J. D., & Hoover, R. N. (2007). Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. Journal of the National Cancer Institute, 99, 1152-1161.
Hewitt, M., Greenfield, S., & Stovall, E. (2006). From cancer patient to cancer survivor: Lost in transition. Washington, DC: National Academies Press.
Institute of Medicine. (2001). Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academies Press.
Kooken, W. C., Haase, J. E., & Russell, K. M. (2007). "I've been through something": Poetic explorations of African American women's cancer survivorship. Western Journal of Nursing Research, 29, 896-919.
Meneses, K., McNees, P., Azuero, A., Loerzel, V. W., Su, X., & Hassey, L. A. (2009). Preliminary evaluation of psychoeducational support interventions on quality of life in rural breast cancer survivors after primary treatment. Cancer Nursing, 32, 385-397.
Meneses, K. D., McNees, P., Loerzel, V. W., Su, X., Zhang, Y., & Hassey, L. A. (2007). Transition from treatment to survivorship: Effects of a psychoeducational intervention on quality of life in breast cancer survivors. Oncology Nursing Forum, 34, 1007-1016. doi:10.1188/07.ONF.1007-1016
Mishel, M. H., Germino, B. B., Gil, K. M., Belyea, M., Laney, I.C, Stewart, J., … Clayton, M. (2005). Benefits from an uncertainty management intervention for African-American and Caucasian older long-term breast cancer survivors. Psycho-Oncology, 14, 962-978.
Morgan, D. L. (1999). Qualitative content analysis: A guide to paths not taken. Qualitative Health Research, 3, 112-121.
Partridge, A., LaFountain, A., Mayer, E., Taylor, B., Winer, E., & Asnis-Alibozek, A. (2006). Adherence with adjuvant anastrozole therapy among women with early stage breast cancer. Journal of Clinical Oncology, 28, 556-562.
Partridge, A., Wang, P., Winter, E., & Avorn, J. (2003). Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. Journal of Clinical Oncology, 21, 602-606.
Patton, M. Q. (1990). Qualitative evaluation and research methods. Newbury Park, CA: Sage.
Rogers, M. E. (1992). Nursing science and the space age. Nursing Science Quarterly, 5, 27-34. doi:10.1177/089431849200500108
Ruddy, K., Mayer, E., & Partridge, A. (2009). Patient adherence and persistence with oral anticancer treatment. CA: A Cancer Journal for Clinicians, 59, 56-66. doi:10.3322/caac.20004
Scheier, M. F., Helgeson, V. S., Schulz, R., Colvin, S., Berga, S., Bridges, M. W., … Pappert, W. S. (2005). Interventions to enhance physical and psychological functioning among younger women who are ending nonhormonal adjuvant treatment for early-stage breast cancer. Journal of Clinical Oncology, 23, 4298-4311. doi:10.1200/JCO.2005.05.362
Stanton, A. L., Ganz, P. A., Kwan, L., Meyerowitz, B. E., Bower, J. E., Krupnick, J. L., … Belin, T. R. (2005). Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients. Journal of Clinical Oncology, 23, 6009-6018. doi:10.1200/JCO.2005.09.101
Stewart, D. W., & Shamdasani, P. N. (1990). Focus groups: Theory and practice. Newbury Park, CA: Sage.
Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q. L., Hu, H., Chemerynsky, I., … Tannock, I. F. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 21, 4175-4183.
Whelan, T. J., Goss, P. E., Ingle, J. N., Pater, J. L., Tu, D., Pritchard, K., … Muss, H. B. (2005). Assessment of quality of life in MA.17: A randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. Journal of Clinical Oncology, 23, 6931-6940. doi:10.1200/JCO.2005.11.181
Winters, L., Habin, K., Flanagan, J., & Cashavelly, B. J. (2010). "I feel like I am 100 years old!" Managing arthralgias from aromatase inhibitors. Clinical Journal of Oncology Nursing, 14, 379-382. doi:10.1188/10.CJON.379-382
Winters, L., Habin, K., & Gallagher, J. (2007). Aromatase inhibitors and musculoskeletal pain in patients with breast cancer. Clinical Journal of Oncology Nursing, 11, 433-439. doi:10.1188/07.CJON.433-439